AU2007215211B2 - Methoxypolyethylene glycol thioester chelate and uses thereof - Google Patents

Methoxypolyethylene glycol thioester chelate and uses thereof Download PDF

Info

Publication number
AU2007215211B2
AU2007215211B2 AU2007215211A AU2007215211A AU2007215211B2 AU 2007215211 B2 AU2007215211 B2 AU 2007215211B2 AU 2007215211 A AU2007215211 A AU 2007215211A AU 2007215211 A AU2007215211 A AU 2007215211A AU 2007215211 B2 AU2007215211 B2 AU 2007215211B2
Authority
AU
Australia
Prior art keywords
compound
pharmaceutically acceptable
patient
cooch
free radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2007215211A
Other languages
English (en)
Other versions
AU2007215211A1 (en
Inventor
Frank A. Lattanzio
Karl A. Schellenberg
James Shaeffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eastern Virginia Medical School
Original Assignee
Eastern Virginia Medical School
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastern Virginia Medical School filed Critical Eastern Virginia Medical School
Publication of AU2007215211A1 publication Critical patent/AU2007215211A1/en
Application granted granted Critical
Publication of AU2007215211B2 publication Critical patent/AU2007215211B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/20Esters of monothiocarboxylic acids
    • C07C327/28Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/04Chelating agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Steroid Compounds (AREA)
AU2007215211A 2006-02-14 2007-02-14 Methoxypolyethylene glycol thioester chelate and uses thereof Ceased AU2007215211B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77287406P 2006-02-14 2006-02-14
US60/772,874 2006-02-14
PCT/US2007/003682 WO2007095178A2 (en) 2006-02-14 2007-02-14 Methoxypolyethylene glycol thioester chelate and uses thereof

Publications (2)

Publication Number Publication Date
AU2007215211A1 AU2007215211A1 (en) 2007-08-23
AU2007215211B2 true AU2007215211B2 (en) 2010-08-26

Family

ID=38372058

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007215211A Ceased AU2007215211B2 (en) 2006-02-14 2007-02-14 Methoxypolyethylene glycol thioester chelate and uses thereof

Country Status (8)

Country Link
US (3) US8008347B2 (https=)
EP (2) EP1986631B1 (https=)
JP (2) JP5138612B2 (https=)
CN (1) CN101394844A (https=)
AT (1) ATE552833T1 (https=)
AU (1) AU2007215211B2 (https=)
CA (1) CA2642453A1 (https=)
WO (1) WO2007095178A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1986631B1 (en) 2006-02-14 2012-04-11 Eastern Virginia Medical School Methoxypolyethylene glycol thioester chelate and uses thereof
WO2010035768A1 (ja) * 2008-09-25 2010-04-01 参天製薬株式会社 ポリアルキレングリコールを有効成分として含有する網膜疾患の予防又は治療剤
TWI568453B (zh) * 2011-11-22 2017-02-01 原創生醫股份有限公司 具有螯合型複合微胞之藥物載體及其應用
JP6086576B2 (ja) * 2012-04-24 2017-03-01 公立大学法人首都大学東京 抗酸化剤
WO2018236221A2 (en) * 2017-06-03 2018-12-27 Can Holding B.V. Neurodegenerative peptide deposit dissolution

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020373A (en) * 1995-10-20 2000-02-01 Eastern Virginia Medical School Chelate derivatives as protectors against tissue injury

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352751A (en) * 1979-09-10 1982-10-05 Analytical Radiation Corporation Species-linked diamine triacetic acids and their chelates
JP2722250B2 (ja) 1989-05-30 1998-03-04 興和株式会社 新規なジアミン化合物及びこれを含有する脳機能障害改善剤
JPH0680964A (ja) * 1991-12-27 1994-03-22 Sogo Yatsukou Kk 活性酸素消去剤
EP0955044B1 (en) * 1995-06-26 2005-11-16 Chelator LLC Method of inhibiting bacterial or fungal growth using a complexing agent
AU7454796A (en) 1995-10-20 1997-05-07 Eastern Virginia Medical School Chelate derivatives as protectors against tissue injury
NZ540885A (en) * 2002-12-20 2009-02-28 Chakshu Res Inc Ophthalmic formulation for the prevention and treatment of ocular conditions
EP1986631B1 (en) * 2006-02-14 2012-04-11 Eastern Virginia Medical School Methoxypolyethylene glycol thioester chelate and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020373A (en) * 1995-10-20 2000-02-01 Eastern Virginia Medical School Chelate derivatives as protectors against tissue injury

Also Published As

Publication number Publication date
CA2642453A1 (en) 2007-08-23
US20080039524A1 (en) 2008-02-14
EP1986631A4 (en) 2010-10-27
EP1986631A2 (en) 2008-11-05
JP2012031173A (ja) 2012-02-16
JP5138612B2 (ja) 2013-02-06
CN101394844A (zh) 2009-03-25
WO2007095178A3 (en) 2008-04-17
WO2007095178A2 (en) 2007-08-23
US7388028B2 (en) 2008-06-17
EP2428234A1 (en) 2012-03-14
US8008347B2 (en) 2011-08-30
US20120016030A1 (en) 2012-01-19
ATE552833T1 (de) 2012-04-15
US20090306205A1 (en) 2009-12-10
US8796336B2 (en) 2014-08-05
JP2009527474A (ja) 2009-07-30
EP1986631B1 (en) 2012-04-11
AU2007215211A1 (en) 2007-08-23

Similar Documents

Publication Publication Date Title
AU2001236856B2 (en) Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
EP1140745B1 (en) Colchinol derivatives as vascular damaging agents
US6184249B1 (en) Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
US6153653A (en) Choline compositions and uses thereof
ES2964818T3 (es) Profármacos de abiraterona
US8796336B2 (en) Methoxypolyethylene glycol chelate and uses thereof
JP2012520342A (ja) 代謝障害を処置するのに有用な抗炎症剤および抗酸化剤のコンジュゲート
KR20060125909A (ko) 이소퀴놀린 유도체 및 이의 사용 방법
CN104203901A (zh) 治疗炎症的组合物和方法
US20190210969A1 (en) Intraesophageal administration of targeted nitroxide agents for protection against ionizing irradiation-induced esophagitis
CA2960750A1 (en) Compositions and methods for treatment of prostate carcinoma
EP1981862B1 (en) Lanthionine-related compounds for the treatment of inflammatory diseases
IL193774A (en) Pharmaceutical compositions containing a 3,5-seco-4-norcholestane derivative
HUE027711T2 (en) An aqueous formulation of improved stability of (E) -4-carboxystyril-4-chlorobenzylsulfone
JPWO2020180942A5 (https=)
JP2006527209A (ja) アシル化及び非−アシル化イミダゾ[2,1−b]−1,3,4−チアジアゾール−2−スルホンアミド及びその使用
EP3866773B1 (en) Carbon monoxide prodrugs for the treatment of medical disorders
EP1289945B1 (en) Aniline disulfide derivatives for treating allergic diseases
US20250026781A1 (en) Prodrugs of Neurosteroid Analogs and Uses Thereof
JP2003342265A (ja) トリアゾリジン誘導体およびその医薬用途
JP2002080368A (ja) 抗炎症薬
HK1050677B (en) Aniline disulfide derivatives for treating allergic diseases
JPWO2000003703A1 (ja) 新規なアレルギー疾患治療剤

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE CO-INVENTOR NAME FROM SHAEFER, JAMES TO SHAEFFER, JAMES

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired